Differential interaction of temperature-sensitive simian virus 40 T antigens with tumor suppressors pRb and p53

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7224-7227

  Ray, Satyajit ^a,b   Anderson, Mary E ^a   Tegtmeyer, Peter ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Endogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS T ANTIGEN;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CELL TRANSFORMATION; CONFORMATIONAL TRANSITION; HEAT SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; SIMIAN VIRUS 40; TUMOR SUPPRESSOR GENE;

EID: 0029792447     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7224-7227.1996     Document Type: Article

References (38)

1. Bargonetti, J., P. N. Friedman, S. E. Kern, B. Vogelstein, and C. Prives. 1991. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083-1091.
2. Bargonetti, J., I. Reynisdottir, P. N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type-p53 to cellular DNA is inhibited by SV40-T antigen and mutant p53. Genes Dev. 6:1886-1898.
3. Botchan, M., W. C. Topp, and J. Sambrook. 1976. The arrangement of simian virus 40 sequences in the DNA of transformed cells. Cell 9:269-287.
4. Cavender, J. F., A. Conn, M. Epler, H. Lacko, and M. J. Tevethia. 1995. Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts. J. Virol. 69:923-934.
5. Chen, J. D., G. J. Tobin, J. M. Pipas, and T. Vandyke. 1992. T-antigen mutant activities in vivo - roles of p53-binding and pRB-binding in tumorigenesis of the choroid plexus. Oncogene 7:1167-1175.
6. Conzen, S. D., and C. N. Cole. 1995. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts. Oncogene 11:2295-2302.
7. DeCaprio, J. A., J. W. Ludlow, J. Figge, J.-Y. Shaw, C.-M. Huang, W.-H. Lee, E. Marsillio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
8. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
9. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
10. Fanning, E. 1992. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J. Virol. 66:1289-1293.
11. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39: 861-869.
12. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
13. Hutchinson, N. I., L.-S. Chang, M. M. Pater, N. Bouck, T. E. Shenk, and G. di Mayorca. 1985. Characterization of a new simian virus 40 mutant, tsA3900, isolated from deletion mutant tsA1499. J. Virol. 53:814-821.
14. Jahn, L., J. Sadoshima, A. Greene, C. Parker, K. G. Morgon, and S. Izumo. 1996. Conditional differentiation of heart- and smooth muscle-derived cells transformed by a temperature-sensitive mutant of SV40 T antigen. J. Cell Sci. 109:397-407.
15. Kaelin, W. G., Jr., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T-antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761-3769.
16. Kierstead, T. D., and M. J. Tevethia. 1993. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67:1817-1829.
17. Lane, D. P., and L. V. Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature (London) 278:261-263.
18. Lee, G. H., K. Ogawa, and N. R. Drinkwater. 1995. Conditional transformation of mouse liver epithelial cells: an in vitro model for analysis of genetic events in hepatocarcinogenesis. Am. J. Pathol. 147:1811-1822.
19. Lin, J.-Y., and D. T. Simmons. 1991. The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. J. Virol. 65:6447-6453.
20. Linzer, L. I. H., and A. J. Levine. 1979. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52.
21. Loeber, G., M. J. Tevethia, J. F. Schwedes, and P. Tegtmeyer. 1989. Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen. J. Virol. 63:4426-4430.
22. Manfredi, J. J., and C. Prives. 1990. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J. Virol. 64:5250-5259.
23. Martin, R. G., and J. Y. Chou. 1975. Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J. Virol. 15:599-612.
24. McCormick, F., R. Clark, E. Harlow, and R. Tjian. 1981. SV40 T antigen binds specifically to a cellular 53 K protein in vitro. Nature (London) 292: 63-69.
25. Quartin, R. S., C. N. Cole, J. M. Pipas, and A. J. Levine. 1994. The aminoterminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J. Virol. 68:1334-1341.
26. Ray, S., M. E. Anderson, G. Loeber, D. McVey, and P. Tegtmeyer. 1992. Functional characterization of temperature-sensitive mutants of simian virus 40 large T antigen. J. Virol. 66:6509-6516.
27. Reynisdóttir, I., and C. Prives. 1992. Two conditional tsA mutant simian virus 40 T antigens display marked differences in thermal inactivation. J. Virol. 66:6517-6526.
28. Schmieg, F. I., and D. T. Simmons. 1988. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site. Virology 164:132-140.
29. Sompayrac, L., and K. J. Danna. 1991. The amino-terminal 147 amino acids of SV40 large T-antigen transform secondary rat embryo fibroblasts. Virology 181:412-415.
30. Srinivasan, A., K. W. C. Peden, and J. M. Pipas. 1989. The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J. Virol. 63:5459-5463.
31. Stenger, J. E., G. A. Mayr, K. Mann, and P. Tegtmeyer. 1992. Formation of stable p53 homotetramers and multiples of tetramers. Mol. Carcinog. 5:102-106.
32. Tegtmeyer, P. 1975. Function of simian virus 40 gene A in transforming infection. J. Virol. 15:613-618.
33. Thompson, D. L., D. Kalderon, A. E. Smith, and M. J. Tevethia. 1990. Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T-antigens. Virology 178:15-34.
34. Wang, Y., M. Reed, P. Wang, J. E. Stenger, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:2575-2586.
35. Weinberg, W. A. 1985. The action of oncogenes in the cytoplasm and nucleus. Science 230:770-776.
36. Welsh, J. D., C. Swimmer, T. Cocke, and T. Shenk. 1986. A second domain of simian virus 40 T antigen in which mutants can alter the cellular localization of the antigen. Mol. Cell. Biol. 6:2207-2212.
37. Yaciuk, P., M. C. Carter, J. M. Pipas, and E. Moran. 1991. Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol. Cell. Biol. 11:2116-2124.
38. Zhu, J. Y., P. W. Rice, L. Gorsch, M. Abate, and C. N. Cole. 1992. Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 66:2780-2791.